CommercialCoverageMedium impact
07.07.09j, Stem-Cell Therapy/Platelet-Rich Plasma for Orthopedic Applications and Platelet-Rich Plasma/Platelet-Derived Growth Factor for Wound Healing and Other Miscellaneous Non-Orthopedic Conditions
Independence Blue Cross·Orthopedics, Wound Care, Sports Medicine +2 more·Medical Policy
Effective date
Mar 5, 2025
We identified it
Jun 19, 2026
Summary
The stem-cell therapy and platelet-rich plasma policy for orthopedic applications and wound healing has been reissued and will take effect March 5, 2025. This policy update affects coverage determinations for regenerative medicine treatments commonly used in orthopedic and wound care practices.
Action Required
Before March 5, 2025: Billing team must review the updated stem-cell therapy and platelet-rich plasma policy at the provided URL to understand any coverage changes. Update prior authorization workflows and verify current coverage criteria for regenerative medicine procedures. Notify providers of any changes to documentation requirements or covered indications.